These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

511 related items for PubMed ID: 18394829

  • 1. One-year therapy with 10mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu.
    Pluchino N, Ninni F, Stomati M, Freschi L, Casarosa E, Valentino V, Luisi S, Genazzani AD, Potì E, Genazzani AR.
    Maturitas; 2008 Apr 20; 59(4):293-303. PubMed ID: 18394829
    [Abstract] [Full Text] [Related]

  • 2. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M, Monteleone P, Casarosa E, Quirici B, Puccetti S, Bernardi F, Genazzani AD, Rovati L, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2000 Oct 20; 14(5):342-63. PubMed ID: 11109974
    [Abstract] [Full Text] [Related]

  • 3. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N, Genazzani AD, Bernardi F, Casarosa E, Pieri M, Palumbo M, Picciarelli G, Gabbanini M, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2005 Mar 20; 20(3):144-9. PubMed ID: 16019353
    [Abstract] [Full Text] [Related]

  • 4. Effect of different hormonal replacement therapies on circulating allopregnanolone and dehydroepiandrosterone levels in postmenopausal women.
    Bernardi F, Pieri M, Stomati M, Luisi S, Palumbo M, Pluchino N, Ceccarelli C, Genazzani AR.
    Gynecol Endocrinol; 2003 Feb 20; 17(1):65-77. PubMed ID: 12724021
    [Abstract] [Full Text] [Related]

  • 5. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan 20; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 6. Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women.
    Genazzani AR, Pluchino N, Begliuomini S, Stomati M, Bernardi F, Pieri M, Casarosa E, Palumbo M, Genazzani AD, Luisi M.
    Gynecol Endocrinol; 2006 Nov 20; 22(11):627-35. PubMed ID: 17145649
    [Abstract] [Full Text] [Related]

  • 7. Progesterone and medroxyprogesterone acetate effects on central and peripheral allopregnanolone and beta-endorphin levels.
    Bernardi F, Pluchino N, Pieri M, Begliuomini S, Lenzi E, Puccetti S, Casarosa E, Luisi M, Genazzani AR.
    Neuroendocrinology; 2006 Nov 20; 83(5-6):348-59. PubMed ID: 16931878
    [Abstract] [Full Text] [Related]

  • 8. Adrenal function under long-term raloxifene administration.
    Genazzani AR, Lombardi I, Borgioli G, di Bono I, Casarosa E, Gambacciani M, Palumbo M, Genazzani AD, Luisi M.
    Gynecol Endocrinol; 2003 Apr 20; 17(2):159-68. PubMed ID: 12737677
    [Abstract] [Full Text] [Related]

  • 9. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
    Ichikawa J, Sumino H, Ichikawa S, Ozaki M.
    Am J Hypertens; 2006 Jul 20; 19(7):744-9. PubMed ID: 16814131
    [Abstract] [Full Text] [Related]

  • 10. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels.
    Chiantera V, Sarti CD, Fornaro F, Farzati A, De Franciscis P, Sepe E, Borrelli AL, Colacurci N.
    Menopause; 2003 Jul 20; 10(4):286-91. PubMed ID: 12851511
    [Abstract] [Full Text] [Related]

  • 11. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.
    Maffei S, Mercuri A, Prontera C, Zucchelli GC, Vassalle C.
    Climacteric; 2006 Dec 20; 9(6):452-8. PubMed ID: 17085378
    [Abstract] [Full Text] [Related]

  • 12. Circadian serum levels of dehydroepiandrosterone sulphate in postmenopausal asthmatic women before and after long-term hormone replacement.
    Kos-Kudla B, Ostrowska Z, Marek B, Ciesielska-Kopacz N, Kudla M, Kajdaniuk D, Siemidska L, Strzelczyk J.
    Endocr Regul; 2001 Dec 20; 35(4):217-22. PubMed ID: 11858769
    [Abstract] [Full Text] [Related]

  • 13. Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone.
    Andréen L, Sundström-Poromaa I, Bixo M, Andersson A, Nyberg S, Bäckström T.
    Psychoneuroendocrinology; 2005 Feb 20; 30(2):212-24. PubMed ID: 15471618
    [Abstract] [Full Text] [Related]

  • 14. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K, Neuenschwander PF, Kurdowska AK.
    Int J Pharm Compd; 2013 Feb 20; 17(1):74-85. PubMed ID: 23627249
    [Abstract] [Full Text] [Related]

  • 15. The effects of hormone replacement therapy on sleep-disordered breathing in postmenopausal women: a pilot study.
    Manber R, Kuo TF, Cataldo N, Colrain IM.
    Sleep; 2003 Mar 15; 26(2):163-8. PubMed ID: 12683475
    [Abstract] [Full Text] [Related]

  • 16. Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women.
    Stomati M, Hartmann B, Spinetti A, Mailand D, Rubino S, Albrecht A, Huber J, Petraglia F, Genazzani AR.
    J Endocrinol Invest; 1996 Sep 15; 19(8):535-41. PubMed ID: 8905477
    [Abstract] [Full Text] [Related]

  • 17. Effect of 1-year, low-dose DHEA therapy on climacteric symptoms and female sexuality.
    Genazzani AR, Stomati M, Valentino V, Pluchino N, Pot E, Casarosa E, Merlini S, Giannini A, Luisi M.
    Climacteric; 2011 Dec 15; 14(6):661-8. PubMed ID: 21942655
    [Abstract] [Full Text] [Related]

  • 18. Effects of a 3-week dehydroepiandrosterone administration on sleep, sex steroids and multiple 24-h hormonal profiles in postmenopausal women: a pilot study.
    Caufriez A, Leproult R, L'Hermite-Balériaux M, Kerkhofs M, Copinschi G.
    Clin Endocrinol (Oxf); 2013 Nov 15; 79(5):716-24. PubMed ID: 23488643
    [Abstract] [Full Text] [Related]

  • 19. A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women.
    Kurtay G, Ozmen B, Erguder I.
    Maturitas; 2006 Jan 10; 53(1):32-8. PubMed ID: 16325022
    [Abstract] [Full Text] [Related]

  • 20. Effects of nonoral estradiol-micronized progesterone or low-dose oral estradiol-drospirenone therapy on metabolic variables and markers of endothelial function in early postmenopause.
    Casanova G, Radavelli S, Lhullier F, Spritzer PM.
    Fertil Steril; 2009 Aug 10; 92(2):605-12. PubMed ID: 18706557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.